Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área de conocimiento
Medicamento(1)
Objetivos de Desarrollo Sostenible
ODS 10: Reducción de las desigualdades(2)
ODS 17: Alianzas para lograr los objetivos(2)
ODS 3: Salud y bienestar(2)
Origen
scopus(2)
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
ArticleAbstract: Background: Cushing's disease is a rare endocrine disorder characterised by cortisol overproductionPalabras claves:Autores:Bertagna X., Biller B.M.K., Findling J.W., Fleseriu M., Gu F., Kim J.H., Lacroix A., Laplanche A., Lee E.J., Leelawattana R., Newell-Price J., O'Connell P., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Shimatsu A., Tauchmanova L.Fuentes:scopusTreatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study
ArticleAbstract: Background: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a rarePalabras claves:classic CAH, classic congenital adrenal hyperplasia, glucocorticoid management, treatment complication, unmet needsAutores:Anatchkova M., Courtillot C., Cutts K., Dobs A., El-Maouche D., Falhammar H., Farrar M., Lacroix A., Lamotte M., O’Donoghue C., Richard J. Auchus, Taylor N., Touraine P., Yonan C.Fuentes:scopus